Viewing Study NCT01045018


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2025-12-26 @ 3:52 AM
Study NCT ID: NCT01045018
Status: COMPLETED
Last Update Posted: 2010-01-08
First Post: 2009-12-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A BE Study Comparing Mesalamine 400 mg to ASACOLĀ® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
Sponsor: EMET Pharmaceuticals, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module